Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis

Clinical trial NCT07335887 · RECRUITING

Trial details

NCT number: NCT07335887
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

AL Amyloidosis (AL)t(11;14) Positive

Start date: 2026-02-10
Primary completion: 2027-12-31
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.